Developer docs
API playgroundTry for free, no card

Search company profiles

OPTIMA

Full company profile

uuid0009enz

Namestring
OPTIMA
Legal namestring
OPTIMA
Company typeenum
Private
Founded yearint
1926
Descriptiontext

OPTIMA is a family-owned German manufacturer of packaging machines, filling machines, and turnkey production facilities, headquartered in Schwäbisch Hall with primary manufacturing operations in Neckarsulm. Founded in 1926 and now operating under a "100 Years of Future" centennial positioning, the company serves nine industry verticals — Pharma and Biotech (primary), Cosmetics and Personal Care, Food, Hygiene, Diagnostics, Medical Products, Chemicals and Household Cleaning, Energy, and Fiber-based packaging — through dedicated divisions including Optima Pharma and Optima Nonwovens. Its core technology stack centers on precision dosing, filling, and packaging platforms for sophisticated liquid and solid products, with notable recent additions including the OPTIMA HSC high-performance cartoning machine, an OLED panel integrating computer-vision code inspection, and the AI-Assist cloud platform for remote troubleshooting.

The business is structured around three revenue streams: (1) one-time equipment sales of packaging machines, filling machines, and turnkey facilities configured per customer specification; (2) recurring service revenue through the OPTIMA Total Care program — maintenance, machine operation, production efficiency, data analytics, and spare-part management — supported by a global service organization of more than 500 technicians; and (3) emerging digital product revenue, including AI-Assist and the Optima Machine Interface. Distribution is conducted exclusively through direct enterprise field sales across 20+ global locations, with no disclosed channel-partner or reseller model, and pricing is quote-based rather than publicly listed.

OPTIMA's strategic emphasis in 2026 is on high-complexity, regulated segments: the ProCell automated CAR-T cell therapy manufacturing system co-developed with ZEISS for live-cell microscopy-monitored production, and the Bottle Collective partnership with PulPac AB and PA Consulting on fiber-based sustainable closures to be showcased at interpack 2026. The firm employs approximately 3,700 people, reports roughly €850 million in annual group turnover, and operates without external private equity or venture capital backing. Recent ESG positioning includes a CSRD-compliant sustainability report and a Platinum sustainability medal.

Short descriptiontext

OPTIMA is a family-owned German manufacturer of packaging machines, filling machines, and turnkey production facilities serving nine verticals — primarily pharma and biotech — through direct enterprise sales and a global service network across 20+ locations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSchwäbisch Hall, Germany
HQ citystring
Schwäbisch Hall
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
packaging machinery, aseptic filling equipment, pharmaceutical packaging, turnkey production lines, cartoning machines
Industry1 code
1Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP)
CodeHLAGAGAGPrimaryYes
NAICS code1 code
  • Commercial and Service Industry Machinery Manufacturing3333
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Industrial Packaging Machinery
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Equipment Sales
TypeOne Time License
Description

Sale of packaging machines, filling machines, and turnkey production facilities for liquid and solid products across multiple industries including pharma, cosmetics, food, and hygiene.

optima-packaging.com
2Service and Maintenance
TypeSubscription Recurring
Description

OPTIMA Total Care service model providing comprehensive support throughout the product lifecycle including maintenance, machine operation, production efficiency, and spare part management.

optima-packaging.com
3Spare Parts
TypeTransaction Fee
Description

Spare part management services for existing machine installations.

optima-packaging.com
4Digital Products and Services
TypeSubscription Recurring
Description

Data analytics, AI-Assist cloud services, and digital products for operational support and optimization.

optima-packaging.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1OPTIMA Nonwovens
Description

Division specializing in nonwovens packaging solutions and services, featuring the OPTIMA HSC high-performance cartoning machine.

nonwovens-industry.com
+1 more record
Core offering1 text field

OPTIMA designs and manufactures industrial packaging machines, filling machines, and complete turnkey production facilities for precise dosing, filling, and packaging of sophisticated liquid and solid products. The company serves nine industry verticals including pharma and biotech, cosmetics, food, hygiene, diagnostics, medical products, chemicals, energy, and fiber-based packaging, with specialized offerings such as the OPTIMA HSC cartoning machine, the ProCell CAR-T cell therapy manufacturing system, and the AI-Assist cloud platform. A comprehensive OPTIMA Total Care service ecosystem provides lifecycle support, maintenance, spare parts, machine operation, and data analytics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 61% reduction in cleanroom space requirements
+1 more record
Product overview1 text field

OPTIMA is a technology-leading manufacturer of packaging machines, filling machines, and turnkey production facilities. The company's portfolio centers on three core product categories: packaging machines, filling machines, and complete turnkey production solutions. These are complemented by specialized offerings including the OPTIMA HSC high-performance cartoning machine with modular design, the ProCell automated CAR-T cell therapy manufacturing system, and the AI-Assist cloud-based troubleshooting platform. OPTIMA serves nine industry verticals (Pharma and Biotech, Cosmetics and Personal Care, Food, Hygiene, Diagnostics, Medical Products, Chemicals and Household Cleaning, Energy, and Fiber-based packaging) with a comprehensive service ecosystem branded as OPTIMA Total Care, covering maintenance, spare parts, production efficiency, and data analytics. The company operates globally with 20 locations, 3,700 employees, and approximately 850 million euros in annual group turnover.

Product and service12 records
1Packaging Machines
CategoryPackaging Machinery
Description

Packaging machines for precise dosing, filling, and packaging of sophisticated liquid and solid products across pharmaceutical, cosmetics, food, hygiene, and other industries. Designed for enterprise manufacturing operations requiring high throughput and format flexibility.

2Filling Machines
CategoryFilling Machinery
Description

Filling systems designed for precise dosing and filling of liquid and solid products in pharmaceutical, cosmetics, food, and other regulated industries. Engineered for aseptic and high-precision applications.

3Turnkey Production Facilities
CategoryProduction Line Systems
Description

Complete turnkey production solutions and facilities for manufacturing operations across pharmaceutical, life science, cosmetics, food, hygiene, and other industries, delivered from initial requirements through commissioning.

4OPTIMA HSC High-Performance Cartoning Machine
CategoryCartoning Machinery
Description

High-performance cartoning machine with modular design, fast format changes, and scalability for packaging operations. Showcased by OPTIMA Nonwovens at the INDEX trade fair in Geneva.

5ProCell Automated CAR-T Cell Therapy Manufacturing System
CategoryCell Therapy Manufacturing Equipment
Description

Automated manufacturing system for CAR-T cell therapy developed by Optima Pharma with integrated ZEISS microscopy technology, enabling real-time monitoring of living cells during production while maintaining GMP compliance and reducing cleanroom space requirements by 61%.

6OPTIMA Total Care
CategoryLifecycle Service and Support
Description

Comprehensive service offering covering the entire product lifecycle including requirements discussion, development, acceptance, and commissioning, delivered by a global service team of 500+ employees.

7Maintenance Services
CategoryMaintenance Services
Description

Comprehensive maintenance services for packaging and filling machines to ensure uptime and operational continuity across customer production sites.

8Spare Part Management
CategorySpare Parts and Aftermarket
Description

Spare part management services to ensure machine uptime and operational continuity for installed OPTIMA equipment.

9Machine Operation Services
CategoryOperational Services
Description

Machine operation services providing OPTIMA personnel to support customer production activities at their sites.

10Production Efficiency Services
CategoryOperational Services
Description

Services focused on optimizing production efficiency, throughput, and reducing operational costs across installed OPTIMA equipment.

11Data Analytics Services
CategoryDigital Services
Description

Data analytics services leveraging machine and production data to optimize production efficiency and machine performance for OPTIMA customers.

12AI-Assist Cloud-Based Troubleshooting System
CategoryDigital Services
Description

Cloud-based AI system for troubleshooting and analysis support, enabling remote diagnostics and maintenance assistance for installed packaging and filling systems. Launched at INDEX 2026 as a digital add-on offering.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PulPac AB developed fiber-based caps as an alternative to plastic closures for packaging applications. Optima served as the machine partner in this collaboration along with PA Consulting. The caps were showcased at interpack 2026 as part of the Bottle Collective initiative exploring integrated fiber-based bottle systems.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

PA Consulting collaborated with PulPac and Optima to develop a new generation of fiber-based caps as an alternative to plastic closures for packaging applications. The collaboration produced promising early test results for the Bottle Collective initiative.

Strategic tierCoreTypeTechnology or Integration
Description

Optima Pharma and ZEISS collaborated to develop ProCell, an automated CAR-T cell therapy manufacturing system. ZEISS microscopy technology is integrated into the system enabling real-time monitoring of living cells during production. The system is installed at Bosch Health Campus in Stuttgart.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Heidelberg University Hospital collaborated on the ProCell CAR-T cell therapy manufacturing project, contributing clinical expertise. The hospital has treated approximately 400 patients with CAR-T therapy and provided clinical input to the technology-medicine partnership.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Stevanato Group is explicitly identified alongside OPTIMA in the fill-finish manufacturing market, providing pharmaceutical vials, syringes, and integrated drug containment/delivery solutions including fill-finish machinery. Both compete for the same pharma fill-finish and packaging equipment RFPs.

TypeDirect peer
Description

Syntegon (formerly Bosch Packaging Technology) is a major global packaging machinery OEM with strength in pharma, food, and liquid processing equipment, competing head-to-head with OPTIMA in turnkey packaging lines and aseptic fill-finish systems for injectables and biologics.

TypeDirect peer
Description

IMA is one of the world's largest packaging machinery manufacturers for pharma, cosmetics, food, and personal care — a near-direct competitor to OPTIMA across its named verticals, with comparable turnkey line capabilities and aseptic processing technology.

TypeBroad incumbent
Description

Krones is a much larger German packaging and bottling machinery incumbent with global scale, particularly dominant in beverage/food packaging — overlapping with OPTIMA's food and hygiene segments but considerably broader in geographic and product reach.

TypeDirect peer
Description

Marchesini is a leading Italian packaging machinery specialist focused on pharma and cosmetics — exactly two of OPTIMA's primary verticals — competing especially on end-of-line, cartoning, and aseptic filling equipment.

TypeBroad incumbent
Description

West Pharmaceutical is a global pharma containment and delivery components supplier with growing integrated systems and fill-finish offerings, competing with Optima Pharma on elastomeric closures, pre-filled syringe systems, and injectables packaging.

TypeBroad incumbent
Description

Gerresheimer is a major global pharma packaging and glass manufacturer that has expanded into integrated devices and aseptic fill-finish, overlapping with Optima Pharma's fill-finish and packaging equipment positioning for injectables and biologics.

TypeDirect peer
Description

Bausch + Ströbel is a German specialist in aseptic fill-finish machinery for vials, syringes, and ampoules — a particularly close peer to Optima Pharma's fill-finish and sterile processing equipment line for pharmaceuticals and ATMPs.

TypeEmerging player
Description

Cytiva (formerly GE Healthcare Life Sciences) provides cell and gene therapy manufacturing platforms and bioreactors — directly adjacent to Optima Pharma's ProCell automated CAR-T manufacturing system, representing both competition and partnership potential in ATMP production automation.

TypeBroad incumbent
Description

ProMach is a large North American packaging machinery integrator with broad capabilities across pharma, food, and consumer goods, overlapping with OPTIMA's diversified nine-vertical portfolio through its multiple operating brands.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment9 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OPTIMA

Industrial Packaging Machineryoptima-packaging-group.de

OPTIMA is a family-owned German manufacturer of packaging machines, filling machines, and turnkey production facilities serving nine verticals — primarily pharma and biotech — through direct enterprise sales and a global service network across 20+ locations.

What OPTIMA does

OPTIMA is a family-owned German manufacturer of packaging machines, filling machines, and turnkey production facilities, headquartered in Schwäbisch Hall with primary manufacturing operations in Neckarsulm. Founded in 1926 and now operating under a "100 Years of Future" centennial positioning, the company serves nine industry verticals — Pharma and Biotech (primary), Cosmetics and Personal Care, Food, Hygiene, Diagnostics, Medical Products, Chemicals and Household Cleaning, Energy, and Fiber-based packaging — through dedicated divisions including Optima Pharma and Optima Nonwovens. Its core technology stack centers on precision dosing, filling, and packaging platforms for sophisticated liquid and solid products, with notable recent additions including the OPTIMA HSC high-performance cartoning machine, an OLED panel integrating computer-vision code inspection, and the AI-Assist cloud platform for remote troubleshooting.

The business is structured around three revenue streams: (1) one-time equipment sales of packaging machines, filling machines, and turnkey facilities configured per customer specification; (2) recurring service revenue through the OPTIMA Total Care program — maintenance, machine operation, production efficiency, data analytics, and spare-part management — supported by a global service organization of more than 500 technicians; and (3) emerging digital product revenue, including AI-Assist and the Optima Machine Interface. Distribution is conducted exclusively through direct enterprise field sales across 20+ global locations, with no disclosed channel-partner or reseller model, and pricing is quote-based rather than publicly listed.

OPTIMA's strategic emphasis in 2026 is on high-complexity, regulated segments: the ProCell automated CAR-T cell therapy manufacturing system co-developed with ZEISS for live-cell microscopy-monitored production, and the Bottle Collective partnership with PulPac AB and PA Consulting on fiber-based sustainable closures to be showcased at interpack 2026. The firm employs approximately 3,700 people, reports roughly €850 million in annual group turnover, and operates without external private equity or venture capital backing. Recent ESG positioning includes a CSRD-compliant sustainability report and a Platinum sustainability medal.

OPTIMA firmographics

Firmographics
Name
OPTIMA
Legal name
OPTIMA
Website
https://optima-packaging-group.de
Company type
Private
Founded year
1926
Operating status
Operating
Headcount range
251–500 employees
Short description
OPTIMA is a family-owned German manufacturer of packaging machines, filling machines, and turnkey production facilities serving nine verticals — primarily pharma and biotech — through direct enterprise sales and a global service network across 20+ locations.
Ownership category
akta.pro rank

OPTIMA industry classification

Industry
Product category
Industrial Packaging Machinery
NAICS
Commercial and Service Industry Machinery Manufacturing (3333)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG)

Keywords

  • Packaging machinery
  • Aseptic filling equipment
  • Pharmaceutical packaging
  • Turnkey production lines
  • Cartoning machines

Where OPTIMA is headquartered

Location

Headquarters

HQ city
Schwäbisch Hall
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

OPTIMA business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Equipment Sales: Sale of packaging machines, filling machines, and turnkey production facilities for liquid and solid products across multiple industries including pharma, cosmetics, food, and hygiene.
  2. Service and Maintenance: OPTIMA Total Care service model providing comprehensive support throughout the product lifecycle including maintenance, machine operation, production efficiency, and spare part management.
  3. Spare Parts: Spare part management services for existing machine installations.
  4. Digital Products and Services: Data analytics, AI-Assist cloud services, and digital products for operational support and optimization.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

OPTIMA product offering

Product offering

Core offering

OPTIMA designs and manufactures industrial packaging machines, filling machines, and complete turnkey production facilities for precise dosing, filling, and packaging of sophisticated liquid and solid products. The company serves nine industry verticals including pharma and biotech, cosmetics, food, hygiene, diagnostics, medical products, chemicals, energy, and fiber-based packaging, with specialized offerings such as the OPTIMA HSC cartoning machine, the ProCell CAR-T cell therapy manufacturing system, and the AI-Assist cloud platform. A comprehensive OPTIMA Total Care service ecosystem provides lifecycle support, maintenance, spare parts, machine operation, and data analytics.

Product overview

OPTIMA is a technology-leading manufacturer of packaging machines, filling machines, and turnkey production facilities. The company's portfolio centers on three core product categories: packaging machines, filling machines, and complete turnkey production solutions. These are complemented by specialized offerings including the OPTIMA HSC high-performance cartoning machine with modular design, the ProCell automated CAR-T cell therapy manufacturing system, and the AI-Assist cloud-based troubleshooting platform. OPTIMA serves nine industry verticals (Pharma and Biotech, Cosmetics and Personal Care, Food, Hygiene, Diagnostics, Medical Products, Chemicals and Household Cleaning, Energy, and Fiber-based packaging) with a comprehensive service ecosystem branded as OPTIMA Total Care, covering maintenance, spare parts, production efficiency, and data analytics. The company operates globally with 20 locations, 3,700 employees, and approximately 850 million euros in annual group turnover.

Differentiator

Problem solved

Functional benefit

Brands

  • OPTIMA Nonwovens: Division specializing in nonwovens packaging solutions and services, featuring the OPTIMA HSC high-performance cartoning machine.
  • OPTIMA Pharma

Products and services

  • Packaging Machines Packaging machines for precise dosing, filling, and packaging of sophisticated liquid and solid products across pharmaceutical, cosmetics, food, hygiene, and other industries. Designed for enterprise manufacturing operations requiring high throughput and format flexibility.
  • Filling Machines Filling systems designed for precise dosing and filling of liquid and solid products in pharmaceutical, cosmetics, food, and other regulated industries. Engineered for aseptic and high-precision applications.
  • Turnkey Production Facilities Complete turnkey production solutions and facilities for manufacturing operations across pharmaceutical, life science, cosmetics, food, hygiene, and other industries, delivered from initial requirements through commissioning.
  • OPTIMA HSC High-Performance Cartoning Machine High-performance cartoning machine with modular design, fast format changes, and scalability for packaging operations. Showcased by OPTIMA Nonwovens at the INDEX trade fair in Geneva.
  • ProCell Automated CAR-T Cell Therapy Manufacturing System Automated manufacturing system for CAR-T cell therapy developed by Optima Pharma with integrated ZEISS microscopy technology, enabling real-time monitoring of living cells during production while maintaining GMP compliance and reducing cleanroom space requirements by 61%.
  • OPTIMA Total Care Comprehensive service offering covering the entire product lifecycle including requirements discussion, development, acceptance, and commissioning, delivered by a global service team of 500+ employees.
  • Maintenance Services Comprehensive maintenance services for packaging and filling machines to ensure uptime and operational continuity across customer production sites.
  • Spare Part Management Spare part management services to ensure machine uptime and operational continuity for installed OPTIMA equipment.
  • Machine Operation Services Machine operation services providing OPTIMA personnel to support customer production activities at their sites.
  • Production Efficiency Services Services focused on optimizing production efficiency, throughput, and reducing operational costs across installed OPTIMA equipment.
  • Data Analytics Services Data analytics services leveraging machine and production data to optimize production efficiency and machine performance for OPTIMA customers.
  • AI-Assist Cloud-Based Troubleshooting System Cloud-based AI system for troubleshooting and analysis support, enabling remote diagnostics and maintenance assistance for installed packaging and filling systems. Launched at INDEX 2026 as a digital add-on offering.

Quantifiable outcome

  • 61% reduction in cleanroom space requirements
  • +1 more outcomes

Companies that use OPTIMA

Customer profile

Named customers1 record

Segments9 records

Ideal customer profiles2 records

OPTIMA technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

OPTIMA partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • PulPac ABcoreStrategic or Co-development PartnerPulPac AB developed fiber-based caps as an alternative to plastic closures for packaging applications. Optima served as the machine partner in this collaboration along with PA Consulting. The caps were showcased at interpack 2026 as part of the Bottle Collective initiative exploring integrated fiber-based bottle systems.
  • PA ConsultingcoreStrategic or Co-development PartnerPA Consulting collaborated with PulPac and Optima to develop a new generation of fiber-based caps as an alternative to plastic closures for packaging applications. The collaboration produced promising early test results for the Bottle Collective initiative.
  • ZEISScoreTechnology or IntegrationOptima Pharma and ZEISS collaborated to develop ProCell, an automated CAR-T cell therapy manufacturing system. ZEISS microscopy technology is integrated into the system enabling real-time monitoring of living cells during production. The system is installed at Bosch Health Campus in Stuttgart.
  • Heidelberg University HospitalcoreStrategic or Co-development PartnerHeidelberg University Hospital collaborated on the ProCell CAR-T cell therapy manufacturing project, contributing clinical expertise. The hospital has treated approximately 400 patients with CAR-T therapy and provided clinical input to the technology-medicine partnership.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

OPTIMA competitors and assessment

Company assessment

Direct peers

  • Stevanato Group: Stevanato Group is explicitly identified alongside OPTIMA in the fill-finish manufacturing market, providing pharmaceutical vials, syringes, and integrated drug containment/delivery solutions including fill-finish machinery. Both compete for the same pharma fill-finish and packaging equipment RFPs.
  • Syntegon Technology: Syntegon (formerly Bosch Packaging Technology) is a major global packaging machinery OEM with strength in pharma, food, and liquid processing equipment, competing head-to-head with OPTIMA in turnkey packaging lines and aseptic fill-finish systems for injectables and biologics.
  • IMA Group: IMA is one of the world's largest packaging machinery manufacturers for pharma, cosmetics, food, and personal care — a near-direct competitor to OPTIMA across its named verticals, with comparable turnkey line capabilities and aseptic processing technology.
  • Marchesini Group: Marchesini is a leading Italian packaging machinery specialist focused on pharma and cosmetics — exactly two of OPTIMA's primary verticals — competing especially on end-of-line, cartoning, and aseptic filling equipment.
  • Bausch + Ströbel Maschinenbau: Bausch + Ströbel is a German specialist in aseptic fill-finish machinery for vials, syringes, and ampoules — a particularly close peer to Optima Pharma's fill-finish and sterile processing equipment line for pharmaceuticals and ATMPs.

Broad incumbents

  • Krones AG: Krones is a much larger German packaging and bottling machinery incumbent with global scale, particularly dominant in beverage/food packaging — overlapping with OPTIMA's food and hygiene segments but considerably broader in geographic and product reach.
  • West Pharmaceutical Services: West Pharmaceutical is a global pharma containment and delivery components supplier with growing integrated systems and fill-finish offerings, competing with Optima Pharma on elastomeric closures, pre-filled syringe systems, and injectables packaging.
  • Gerresheimer AG: Gerresheimer is a major global pharma packaging and glass manufacturer that has expanded into integrated devices and aseptic fill-finish, overlapping with Optima Pharma's fill-finish and packaging equipment positioning for injectables and biologics.
  • ProMach: ProMach is a large North American packaging machinery integrator with broad capabilities across pharma, food, and consumer goods, overlapping with OPTIMA's diversified nine-vertical portfolio through its multiple operating brands.

Emerging players

  • Cytiva: Cytiva (formerly GE Healthcare Life Sciences) provides cell and gene therapy manufacturing platforms and bioreactors — directly adjacent to Optima Pharma's ProCell automated CAR-T manufacturing system, representing both competition and partnership potential in ATMP production automation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

OPTIMA social profiles

Digital presence

OPTIMA compliance and trust

Trust signal

Compliance1 record

OPTIMA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OPTIMA leadership team

Management profile

Number of profiles

OPTIMA subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

OPTIMA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OPTIMA M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OPTIMA

What does OPTIMA do?

OPTIMA designs and manufactures industrial packaging machines, filling machines, and complete turnkey production facilities for precise dosing, filling, and packaging of sophisticated liquid and solid products. The company serves nine industry verticals including pharma and biotech, cosmetics, food, hygiene, diagnostics, medical products, chemicals, energy, and fiber-based packaging, with specialized offerings such as the OPTIMA HSC cartoning machine, the ProCell CAR-T cell therapy manufacturing system, and the AI-Assist cloud platform. A comprehensive OPTIMA Total Care service ecosystem provides lifecycle support, maintenance, spare parts, machine operation, and data analytics.

Is OPTIMA a public or private company?

OPTIMA is a private company. It is classified as family owned and is currently operating.

When was OPTIMA founded?

OPTIMA was founded in 1926. It employs 251 to 500 people.

Where is OPTIMA based?

OPTIMA is headquartered in Schwäbisch Hall, Germany, in the Europe region.

How does OPTIMA make money?

Four revenue lines are on record. Equipment Sales are the primary driver. The others are service and Maintenance, spare Parts and digital Products and Services.

Who are OPTIMA's main competitors?

Direct peers on record are Stevanato Group, Syntegon Technology, IMA Group, Marchesini Group and Bausch + Ströbel Maschinenbau. Broad incumbents are Krones AG, West Pharmaceutical Services, Gerresheimer AG and ProMach. Cytiva is listed as an emerging player.

Does OPTIMA have an API?

No public API is recorded for OPTIMA.

What industry is OPTIMA in?

OPTIMA's product category is Industrial Packaging Machinery. Its primary akta.pro industry code is HLAGAGAG, Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP). Its NAICS code is 3333 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Precedence ResearchDual Chamber Syringe Filling Machine Market Size to Hit USD 880.88 Million by 2035The global dual chamber syringe filling machine market is projected to grow from USD 392.09 million in 2025 to USD 880.88 million by 2035, expanding at a CAGR of 8.43%, driven by increasing demand for prefilled and lyophilized injectable drug formats in the biopharmaceutical industry. North America dominated the market with a 52.4% share in 2025, while Asia Pacific is expected to be the fastest-growing region at 8.5% CAGR. Key market drivers include the rapid growth of biologics and biosimilars, heightened regulatory emphasis on sterility and contamination control, and the integration of AI-based inspection and predictive maintenance systems, with major pharmaceutical companies including Pfizer, Roche, and AstraZeneca identified as key investors alongside equipment manufacturers Syntegon, OPTIMA, and IMA Group.Nonwovens-industryOptima Nonwovens to Demonstrate Modern Packaging SolutionsOptima Nonwovens announced it will showcase its packaging and service solutions at the INDEX trade fair in Geneva under the motto 'Shaping your future with our pioneering flexibility.' The company will feature the OPTIMA HSC high-performance cartoning machine with modular design, fast format changes, and scalability, alongside practical upgrades and retrofit solutions for existing systems. Additional highlights include an OLED panel with intelligent features such as product counting, code inspection, and laser printing, as well as cloud-based AI-Assist for troubleshooting and analysis support.ZEISSAdvanced CAR-T Cell Therapy SolutionsA new automated CAR-T cell therapy manufacturing system called ProCell, developed by Optima Pharma and equipped with ZEISS microscopy technology, is being installed at the Bosch Health Campus in Stuttgart, Germany, representing a shift toward more scalable and accessible personalized cancer treatment. The system enables real-time monitoring of living cells during production, reducing manual processing, cleanroom space by 61%, and specialized personnel requirements while maintaining GMP compliance. Heidelberg University Hospital, which has treated approximately 400 patients with CAR-T therapy, collaborated on the project, contributing clinical expertise to the technology-medicine partnership.ContractpharmaProCell for Patient Project to Develop Automated Production Unit for CAR-T Cell TherapiesA project named "ProCell for Patient" has been launched by the Robert-Bosch-Krankenhaus in Stuttgart, the Universitätsklinikum Heidelberg, and the Pharma Division of Optima to create an automated production system for CAR-T cell therapies. This initiative aims to reduce production hours for CAR-T cells by at least 50%, improving patient care significantly. The prototype is set to be installed at the RBK in the summer of 2022, with plans for broader rollout after testing and trials.